GlassScriptPhysician profile
Caleb Ogden Pinegar
NPI 1588793533
$13,906.64
in general payments reported to CMS, 2019-2025
9 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,678 · 2020: $2,341 · 2021: $3,545 · 2022: $21.09 · 2023: $5,340 · 2024: $797 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,398 · Food and Beverage: $2,113 · Long Term Medical Supply Or Device Loan: $605 · Education: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,397.64 |
| Food and Beverage | $2,113.49 |
| Long Term Medical Supply Or Device Loan | $604.78 |
| Education | $205.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $9,799.12 | 2019-2025 | |
| Arthrex, INC. | $2,347.01 | 2019-2023 | Arthrex |
| Integra Lifesciences Corporation | $604.78 | 2024 | Acell |
| Smith+Nephew, INC. | $493.85 | 2019-2023 | Pico |
| Depuy Synthes Sales INC. | $335.57 | 2021-2025 | Monovisc, Orthovisc |
| Orthofix Medical, INC. | $150.87 | 2019-2024 | Physio-Stim |
| Abbott Laboratories | $127.27 | 2023 | Proclaim |
| Bioventus LLC | $31.89 | 2019 | |
| Zyla Life Sciences, INC. | $16.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Pinegar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.